The economics of litigation continue to receive more attention. For example, an April, 29, 2016 post at CLS Blue Sky Blog brings news of...

See the April 26, 2016 post from Jim Beck at Drug and Device blog.

Immunotherapy for cancer is the new thing, and it shows great promise, but also difficulties. For a good overview explanation, see this...

Epigenetics. It’s a big deal, and is more and more becoming part of main stream conversations. For a very readable explanation, see Same...

An ounce of prevention versus ………. VW’s $18 billion charge for the emissions cheating scandal provides a timely example of the need to...

Looking for a great, real cyber-crime story with lawyers as some of the good guys? Read Michael Goldhaber’s great account in the American...

An April 4, 2016 Blue Sky blog article from Professor Coffee provides a cogent review of the end of the SCOTUS pendulum swinging against...

Publicity is growing in regular media regarding the Indiana Supreme Court knocking out the state’s construction statute of reposed based...

A brief review of the BAP1 “meso gene” discovery story is provided  – with links to key articles – in the April 1, 2016  issue of the...

It can be interesting to peel back onion skin layers of law and find new legal rules. Consider for example the following two paragraphs...

This headline made my morning:  “Posner Calls Bluebook ‘Rubbish’ In Legal Profession Critique”  It’s from a LAW360 story online here.  ...

Directors and officers face increasing risks of criminal prosecution by DOJ and federal agencies, as described in a March 25, 2016 blog...

False claims litigation continues as a steady segment of the ever-growing litigation industry. New numbers and comments are set out in a...

The ironic saga continues as litigation funders are firmed up for securities suits against Slater & Gordon, a well-known plaintiff’s firm...

Genes, the immune system, and schizophrenia; how are they linked? The New Yorker provides a compelling excerpt from the explanation set...

Excluding Justices Thomas and Alito,  SCOTUS this week not surprisingly concluded that statistical proof can be used in class actions to...

Some members of the patent bar remain anxious to see patents sprawl across the ongoing revolution in molecular biology, as illustrated by...

The world of corporate litigation continues to draw interesting comments, as described in a March 17, 2016 story at DealBook at the New...

A settlement, sort of,  for Garlock and Coltec was announced late yesterday. The deal has multiple moving parts, including a new chapter...

It appears more will soon be written on when, if ever, bankruptcy courts can cut off product liability claims against successor entities....